MoonLake Immunotherapeutics MLTX
10.98 USD -0.72 (-6.15%)
Nov 4, 2026, 11:05 AM EST
10.96 Day range 11.93
9.46 52-week range 23.29
- YTD
- -16.69%
- 1 year
- +8.39%
Held by funds
16 US ETFs and mutual funds hold MLTX · largest positions
Ownership
Held by insiders 8.18%
Held by institutions 87.73%
Float held by institutions 95.54%
Institutions 222
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| BVF Inc. | 18.80% | 16,001,284 | 188.50M | Jun 29, 2026 |
| Deep Track Capital, Lp | 8.22% | 6,999,025 | 82.45M | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 5.03% | 4,280,624 | 50.43M | Jun 29, 2026 |
| Shaw D.E. & Co., Inc. | 3.95% | 3,365,507 | 39.65M | Jun 29, 2026 |
| Cormorant Asset Management, LP | 3.77% | 3,205,433 | 37.76M | Jun 29, 2026 |
| Jupiter Topco LLC | 3.63% | 3,085,906 | 36.35M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 1.90% | 1,614,289 | 19.02M | Jun 29, 2026 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 1.08% | 918,586 | 10.82M | Jun 29, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.93% | 792,072 | 9.33M | Jun 29, 2026 |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Value Equity Trust | 0.71% | 605,474 | 7.13M | Jun 29, 2026 |
| JNL Series Trust-JNL/T. Rowe Price Capital Appreciation Fund | 0.41% | 350,134 | 4.12M | Jun 29, 2026 |
| T. Rowe Price Exch-Trd Fd.s, Inc.-T Rowe Price Capital Appreciation Eq | 0.20% | 167,768 | 1.98M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BODENSTEDT MATTHIAS | Chief Financial Officer | Sale | Jun 21, 2026 | 1,115,440 |
| BVF PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 30, 2026 | 0 |
| CHEN BIHUA X. | Former | Sale | Sep 29, 2025 | 0 |
| MOUKHEIBIR CATHERINE | Director | Sale | Jul 2, 2025 | 0 |
| REICH KRISTIAN | Officer | Sale | Jul 26, 2026 | 0 |
| SANTOS DA SILVA JORGE | Chief Executive Officer | Sale | Jul 9, 2026 | 2,774,890 |